News Focus
News Focus
Followers 57
Posts 3704
Boards Moderated 0
Alias Born 10/26/2013

Re: Rkmatters post# 84879

Thursday, 11/24/2016 8:56:19 AM

Thursday, November 24, 2016 8:56:19 AM

Post# of 817886
OK, I may get slammed for this post but why can’t this trial receive conditional approval for rGBM too? Longs are hoping for AA in newly diagnosed GBM with PFS1 and full approval in ndGBM when OS comes to maturation but at crossover pts will be getting dosed again so they could possibly get statistically significant data (mesenchymal?) OS data from that. At crossover, there will be no placebo to compare to so that’s why I’m thinking AA only. They would then have to run a placebo controlled trial in rGBM to get full approval.

Happy Thanksgiving to all…and to those w upcoming birthdays, Happy Birthday. :)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News